CLINICAL_TRIALS trial_result · 2024-04-25

Clinical Trial Update: Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy [Phase 3]

A Phase 3 trial of denosumab in advanced non-small cell lung cancer showed survival improvement; the study was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: ETOP IBCSG Partners Foundation | Conditions: Lung Cancer Non-small Cell Stage IV | Phase 3 | Status: TERMINATED | Results posted: 2024-04-25